Belite Bio (BLTE) Times Interest Earned (2022 - 2026)
Belite Bio (BLTE) posted quarterly Times Interest Earned of $2.48 for Q1 2026, up 100.0% year-over-year from $1.24 in Q1 2025, and up 103443.81% quarter-over-quarter from -$0.0 in Q4 2025.
Belite Bio (BLTE) Times Interest Earned (2022 - 2026) Analysis & Trends
Belite Bio's Times Interest Earned history runs 5 years deep, the most recent figure standing at $2.48 for Q1 2026.
- In Q1 2026, Times Interest Earned rose 100.0% year-over-year to $2.48; the TTM figure through Mar 2026 stood at $11903.3 (up 100.19% YoY), while the FY2025 annual figure was -$0.23, down 60.01% from the prior year.
- Times Interest Earned for Q1 2026 stood at $2.48, up from -$0.0 in the prior quarter.
- The five-year high for Times Interest Earned was $2724.0 in Q4 2024, with the low at -$20.0 million in Q4 2023.
- The 5-year median for Times Interest Earned is -$320872.7 (2022), against an average of -$3.8 million.
- The sharpest annual moves came in 2023 and 2024: Times Interest Earned slumped 3023.24% in 2023, then soared 100.01% in 2024.
- Belite Bio's Times Interest Earned stood at -$641745.4 in 2022, then plunged by 3023.24% to -$20.0 million in 2023, then surged by 100.01% to $2724.0 in 2024, then sank by 100.0% to -$0.0 in 2025, then soared by 103443.81% to $2.48 in 2026.
- Business Quant data shows BLTE's Times Interest Earned at $2.48 in Q1 2026, -$0.0 in Q4 2025, and -$2.3 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Belite Bio | 6.40 Bn | 6.40 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.48 |
| Dec 31, 2025 | 0.00 |
| Mar 31, 2025 | -2.33 Mn |
| Dec 31, 2024 | 2,723.97 |
| Dec 31, 2023 | -20.04 Mn |
| Dec 31, 2022 | -641,745.44 |